Valuation Evofem Biosciences, Inc.

Stocks

Real-time OTC Markets 15:59:24 2026-06-04 EDT			5-day change	1st Jan Change
0.008500 ^USD	+7.59%		+32.81%	-10.53%

09-23	Evofem Biosciences, Inc. Adds Additional Manufacturing Capacity for Phexx to Support Global Growth Strategy	CI
08-14	Evofem Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	195.9	61.26	7.886	1.281	1.122	1.204
Change	-	-68.73%	-87.13%	-83.76%	-12.37%	7.24%
Enterprise Value (EV) ¹	232.9	169.2	76.25	44.65	46.96	55.62
Change	-	-27.36%	-54.94%	-41.43%	5.17%	18.44%
P/E	-1.14x	-0.24x	-0.05x	1.2x	-0.08x	26.7x
PBR	146x	-0.58x	-0.11x	-0.02x	-0.02x	-0.02x
PEG	-	0x	0x	-0x	0x	-0x
Capitalization / Revenue	439x	7.43x	0.47x	0.07x	0.06x	0.06x
EV / Revenue	522x	20.5x	4.53x	2.45x	2.43x	2.76x
EV / EBITDA	-2.26x	-1.02x	-0.92x	-2.57x	-6.68x	28.4x
EV / EBIT	-2.25x	-1.01x	-0.91x	-2.5x	-6.12x	38.7x
EV / FCF	-2.55x	-2.42x	-2.01x	-6.24x	-12.4x	-9.51x
FCF Yield	-39.2%	-41.4%	-49.8%	-16%	-8.04%	-10.5%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-3,973	-2,962	-167.5	0.0535	-0.12	0.000356
Distribution rate	-	-	-	-	-	-
Net sales ¹	0.446	8.244	16.84	18.22	19.36	20.18
EBITDA ¹	-103.2	-165.8	-83.11	-17.37	-7.027	1.957
EBIT ¹	-103.5	-166.8	-84.12	-17.85	-7.676	1.439
Net income ¹	-142.3	-205.2	-76.7	52.98	-8.86	0.391
Net Debt ¹	37.05	108	68.36	43.37	45.84	54.42
Reference price ²	4,518.747740	704.062147	8.000000	0.064000	0.009900	0.009500
Nbr of stocks (in thousands)	43.3	87	986	20,011	113,356	126,686
Announcement Date	3/4/21	3/10/22	4/27/23	3/27/24	3/24/25	3/11/26

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
EVOFEM BIOSCIENCES, INC.	-	-	-	-	815K
ELI LILLY AND COMPANY	40.35x	13.85x	30.26x	0.5%	1,224B
JOHNSON & JOHNSON	40.28x	6.76x	19.02x	1.94%	662B
ABBVIE INC.	38.08x	8.51x	17.61x	2.36%	514B
ROCHE HOLDING AG	21.65x	5.25x	13.07x	2.49%	388B
MERCK & CO., INC.	106.67x	5.95x	25.48x	2.33%	361B
NOVARTIS AG	22.86x	5.89x	14.22x	2.75%	302B
ASTRAZENECA PLC	22.82x	4.6x	13.15x	1.92%	271B
AMGEN INC.	29.23x	7.45x	13.34x	2.19%	249B
GILEAD SCIENCES, INC.	-47.64x	7.37x	28.55x	1.99%	205B
Average	30.48x	7.29x	19.41x	2.05%	417.68B
Weighted average by Cap.	36.66x	8.71x	21.55x	1.73%